Alan P. Lyss, MD

All articles by Alan P. Lyss, MD

Breast cancer

On-Treatment Ki-67: A Promising Prognostic Marker for Early Breast Cancer Management

By

Alan P. Lyss, MD

July 12, 2021

Dr Alan Lyss reviews results from the high-risk cohort of the WSG-ADAPT HR+/HER2- trial.

Next post in Breast Cancer

Breast cancer consultation

Adding Alpelisib to Fulvestrant Doesn’t Impact HRQOL in Advanced Breast Cancer